|
Research and Markets: This Essential Nanoparticle Drug Delivery Report
is Now Available
(M2 PressWIRE Via Acquire Media NewsEdge)
RDATE:12112008
Dublin - Research and
Markets(http://www.researchandmarkets.com/research/13d89a/nanoparticle_d
rug) has announced the addition of the "Nanoparticle Drug Delivery"
report to their offering.
Advances in nanotechnology that enable drugs to be delivered in ways
that preserve their efficacy and to precise therapeutic targets are
creating a host of opportunities for drug developers. A variety of
nanostructures are being investigated as functional drug carriers for a
wide range of therapies, most notably cardiovascular medicine,
autoimmune diseases, and cancer. While the concept of nanoparticles in
drug delivery is not new, the number of research programs and active
drug development projects has escalated as funding to nanotechnology
developers has increased. The result is the emergence of a host of
novel nanotechnologies tailored to meet the physicochemical
requirements of drug developers. Nanoparticles have already improved
the availability and efficacy of some drugs, and the capabilities that
evolving technologies possess will leads to a dramatic increase in the
number of therapies delivered via nanoparticles
The study presents qualitative and quantitative data and information on
key demand factors and trends:
- Nanoparticle Technology Competitive Assessment
- Nanoparticle Drug Development Factors
- Near-Term Nano-Drug Disease Therapies
- Nanoparticle Technology Commercialization Issues
- Technology-driven Performance Factors
- Opportunity Assessment and Factors Limiting Growth
- Drug Design and Development Factors
- Sector Participant Profiles
Key Topics Covered:
Executive Summary
Engineered Drug Delivery Market Overview
- Market Dynamics
- Competitive Landscape
- Demand Drivers
- Factors Limiting Growth
Nanoparticle Design & Technology Factors
- Drug Solubility
- Dosage Forms
- Pharmacokinetics
- Bioavailability
Commercial Nanoparticle Platform Assessment
- Mucoadhesive Nanospheres
- Composite Nanoshells
- Magnetic Nanoparticles
- Quantum Dots
- Optical Activation
- Emerging Nanoparticle Delivery Technologies
Nanoparticle Drug Delivery Market Drivers
- Safety
- Targeted Drug Delivery
- Funding Programs
- Patient/Consumer Sentiment
- Enhanced Compliance
Near-term Nanoparticle Delivery Therapeutics
- Autoimmune Diseases
- Cardiovascular Medicine
- Cancer Therapy
- Musculoskeletal
- Vaccines
- Emerging Markets
- Existing/Approved Drugs
- New Drug Discovery
- DNA-based Therapies
Market Factors
- Government Regulations
- Health Standards Organizations
- Growth of Self-Administration
- Managed Care Initiatives
- Shifting Patient Demographics
- Patent Expiry and Generics
- Rx-to-OTC Switching
Nanoparticle Drug Delivery - Company Profile
For more information visit
http://www.researchandmarkets.com/research/13d89a/nanoparticle_drug
CONTACT: Laura Wood, Senior Manager, Research and Markets
Fax: +1 646 607 1907 (US)
Fax: +353 1 481 1716 (Rest of World)
e-mail: press@researchandmarkets.com
((M2 Communications Ltd disclaims all liability for information
provided within M2 PressWIRE. Data supplied by named party/parties.
Further information on M2 PressWIRE can be obtained at
http://www.presswire.net on the world wide web. Inquiries to
info@m2.com)).
Copyright ? 2008 M2 Communications Ltd.
[ Back To TMCnet.com's Homepage ]
|
INDUSTRIES
Activate Email 
Find Solutions for Enterprises, SMBs & Service Providers at the INTERNET TELEPHONY Conference and EXPO East, January 20-22, 2010. Miami, FL.
